Systemic corticosteroid use in orbital lymphangioma.
OBJECTIVE
To describe the clinical results of systemic corticosteroid use in a series of patients with orbital lymphangioma.


METHODS
Four patients (two adults and two children) were treated with corticosteroids using intravenous, oral, or both routes for 2 days to a month. Corticosteroids were used with and without other therapies for symptomatic exacerbations.


RESULTS
The adults showed more improvement with pain than with swelling, whereas the children had improvement with both the signs and symptoms. There were no complications in any patient.


CONCLUSIONS
Systemic corticosteroids are a useful therapeutic option for patients with orbital lymphangioma and can be used as an adjuvant treatment to surgery and other modalities. Resolution of symptoms with corticosteroids was expedited compared with the natural history of the disease in the patients studied.
Sires
B S
BS
Department of Ophthalmology, University of Washington, Seattle 98195-6485, USA.
Goins
C R
CR
Anderson
R L
RL
Holds
J B
JB
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008202:Lymphangioma / Q000175:diagnosis / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D005938:Glucocorticoids; D003907:Dexamethasone; D011241:Prednisone